A mind-body program to help cancer survivors manage fear of recurrence
A Multimodal Mind-Body Intervention for Fear of Recurrence among Cancer Survivors
This study is creating a friendly program to help cancer survivors manage their worries about cancer coming back, using relaxation, mindfulness, and positive thinking, and we want to hear from patients to make it even better!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10681222 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a comprehensive mind-body intervention aimed at helping cancer survivors cope with their fear of recurrence, a common and distressing concern. The program incorporates relaxation techniques, mindfulness meditation, cognitive-behavioral strategies, and positive psychology to address these fears. Through focus groups and interviews, the intervention will be refined based on patient feedback, and its feasibility and acceptability will be evaluated in a pilot randomized controlled trial. This approach aims to improve healthcare engagement and overall well-being for cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors, particularly those experiencing elevated fears of recurrence.
Not a fit: Patients who are currently undergoing active cancer treatment or those without a history of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce fear of recurrence in cancer survivors, leading to improved mental health and better healthcare engagement.
How similar studies have performed: Previous studies have shown promise in using mind-body interventions to address psychological concerns in cancer survivors, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Hall, Daniel Lee — Massachusetts General Hospital
- Study coordinator: Hall, Daniel Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.